In 2026, the USMCA will undergo an open-ended review that could result in anything from minor changes to significant renegotiations. Nonresident fellow Simon Lester discusses this unprecedented process and argues that the U.S. and Mexico must follow Canada’s lead in starting preparations.
While the U.S. has tried to appear assertive in taking action against China’s trade practices, this strategy has yielded limited results. In a new commentary, fellow Simon Lester summarizes current U.S. policies addressing China’s trade conduct and advocates for the U.S.’ revitalized engagement with the World Trade Organization’s dispute settlement system.
The Office of the United States Trade Representative recently stepped back from ongoing negotiations on digital trade at the World Trade Organization, citing unsettled domestic policy, and suspended support for digital trade rules in the Indo-Pacific Economic Framework too. But if the U.S. wants to be a part of the conversation, it should reengage and help craft rules flexible enough to meet its future domestic policy needs, writes nonresident fellow Simon Lester.
Despite recent claims that “free trade is dead,” fellow Simon Lester explains that America was never close to anything resembling free trade in the first place. Instead, current U.S. trade policy, just like past policy, reflects a messy mix of free market and industrial policy views.
With the recent enactment of the CHIPS and Science Act, the conversation about industrial policy has started up again. Are state-directed economic policies back, and will such initiatives work?
Some states still face challenges with racial and ethnic disparities in COVID-19 vaccine distribution, and Texas is one of them. How might we avoid these inequities in the future? The authors explain in the Baker Institute Blog.
Elena M. Marks, Varsha Varghese, Jennifer MeierMay 5, 2021
An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.